Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

NCT01805258 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

HIV/TB Co-infection

Interventions

DRUG: Nevirapine
DRUG: Efavirenz

Sponsor

All India Institute of Medical Sciences

Collaborators

[object Object]